New GSK Logo On Products

GSK, RSV and Shingles

GSK's RSV vaccine meets main goal when co-administered with shingles shot

British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles shot, met the main goal of a late-stage trial in adults over 50 years of age.

BioSpace · 1d

GSK Builds Combo Case for RSV, Shingles Shots With Phase III Data

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients and potentially bolster GSK’s faltering sales for both vaccines.

Business Insider · 1d

GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines

GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the

Reuters on MSN · 2d

GSK's RSV, Shingles vaccines show on-par immune response in joint trial

(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage trial as separate adminstration of the vaccines.

Seeking Alpha on MSN · 1d

GSK posts late-stage trial win for co-administered RSV and shingles vaccines

GSK (NYSE:GSK) announced Wednesday that its Arexvy vaccine for respiratory syncytial virus (RSV) and its Shingrix vaccine for shingles reached the main goal in a Phase 3 trial when they were co-administered in adults aged 50 and older.

Creative Review2y

Wolff Olins overhauls GSK’s identity

The GSK name and elements of the incumbent orange logo have been retained in the new identity. Stevens says that the decision to retain the orange was partly driven by the fact that “the world ...

pharmaphorum9d

GSK under pressure to rein in new CEO pay

GlaxoSmithKline is under pressure ... pinpo The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns ...

WFMZ-TV2y

New GSK posts strong 2Q results

After several years of anticipation, it’s a new GSK. And so far, the results look pretty good. The company, with facilities in Collegeville and Valley Forge, reported positive second quarter ...

GSK settles two California lawsuits related to heartburn drug Zantac

British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued ...

MedCity News1mon

GSK, Flagship Pioneering Commit $150M to Start R&D Pact for Novel Drugs and Vaccines

which commercialized a Covid-19 messenger RNA vaccine and is continuing to leverage its platform technology to develop new mRNA vaccines for infectious diseases and cancer. GSK and Flagship aim to ...

Bloomberg on MSN4mon

GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay

The investor, who declined to be identified, pointed to Astra’s steadier flow of new products. Philip Hampton, GSK’s ...

Jefferies Sticks to Their Buy Rating for GlaxoSmithKline (GSK)

In a report released today, Peter Welford from Jefferies maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

pharmaphorum2d

GSK says Nucala hits the target in new COPD trial

The drug remains one of GSK's top products, with sales of £856 million ($1.1 billion) in the first half of this year, up 15%. COPD could open up a massive new market for the drug, which still ...

AutoTrader.co.uk2mon

GSK Cars

GSK Cars: Your Premier Destination for Quality Vehicles At GSK Cars, we pride ourselves on offering an extensive selection of high-quality vehicles to suit every need and budget. Located ...

GSK: Japan Accepts For Review NDA For Blenrep Combinations In Relapsed/refractory Multiple Myeloma

Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results